Lv4
500 积分 2023-05-05 加入
[Expert consensus on the application of rituximab in the treatment of membranous nephropathy]
11个月前
已完结
[Chinese guideline on the diagnosis and treatment of thyroid-associated ophthalmopathy (2022)]
11个月前
已完结
利妥昔单抗对肾小球疾病患者血淋巴细胞及免疫球蛋白的影响
11个月前
已完结
Chidamide Plus R-GemOx(rituximab, gemcitabine and oxaliplatin) Regimen As Salvage Treatment for Transplant-Ineligible Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Preliminary Analysis of a Multicenter, Single Arm, Phase II Study
11个月前
已关闭
消化性溃疡基层诊疗指南（2023年）
1年前
已完结
Anti-glomerular basement membrane diseases and thrombotic microangiopathy treated with rituximab
1年前
已完结
Anti-glomerular basement membrane disease: Treatment outcome of cyclophosphamide vs. rituximab induction therapy regimen
1年前
已完结
Anti-glomerular basement membrane disease: Treatment outcome of cyclophosphamide vs. rituximab induction therapy regimen
1年前
已完结
Pharmacology of fenofibrate
1年前
已完结
[IgA nephropathy and granulomatosis with polyangiitis-overlap: a rare coexistence of two glomerular nephropathies with remission after steroids and rituximab]
1年前
已关闭
皖公网安备34019202002308
